Mental Health TechnologiesLtd Full Year 2024 Earnings: EPS Misses Expectations

Mental Health TechnologiesLtd (TSE:9218) Full Year 2024 Results

Key Financial Results

• Revenue: JP¥5.13b (up 97% from FY 2023).
• Net loss: JP¥29.0m (down by 107% from JP¥441.0m profit in FY 2023).
• JP¥2.85 loss per share (down from JP¥44.25 profit in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Mental Health TechnologiesLtd EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 192%.

Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Healthcare Services industry in Japan.

Performance of the Japanese Healthcare Services industry.

The company's shares are up 4.1% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Mental Health TechnologiesLtd has 3 warning signs (and 1 which can't be ignored) we think you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.